NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 184 filers reported holding NEVRO CORP in Q3 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,058,543 | -24.1% | 55,076 | +0.4% | 0.00% | -50.0% |
Q2 2023 | $1,394,007 | +81804.1% | 54,839 | +16.5% | 0.00% | 0.0% |
Q1 2023 | $1,702 | -7.2% | 47,080 | +1.6% | 0.00% | 0.0% |
Q4 2022 | $1,835 | -99.9% | 46,336 | +3.5% | 0.00% | -33.3% |
Q3 2022 | $2,087,000 | +14.9% | 44,778 | +8.0% | 0.00% | 0.0% |
Q2 2022 | $1,816,000 | -30.5% | 41,443 | +14.7% | 0.00% | 0.0% |
Q1 2022 | $2,614,000 | -10.3% | 36,136 | +0.6% | 0.00% | -25.0% |
Q4 2021 | $2,913,000 | -31.6% | 35,926 | -1.8% | 0.00% | -33.3% |
Q3 2021 | $4,260,000 | -28.6% | 36,602 | +1.7% | 0.01% | -25.0% |
Q2 2021 | $5,966,000 | +13.9% | 35,986 | -4.2% | 0.01% | +14.3% |
Q1 2021 | $5,239,000 | -28.7% | 37,553 | -11.5% | 0.01% | -30.0% |
Q4 2020 | $7,347,000 | +28.5% | 42,444 | +3.4% | 0.01% | +11.1% |
Q3 2020 | $5,716,000 | -8.5% | 41,034 | -21.5% | 0.01% | -10.0% |
Q2 2020 | $6,245,000 | +43.7% | 52,276 | +20.3% | 0.01% | +11.1% |
Q1 2020 | $4,345,000 | -13.8% | 43,457 | +1.3% | 0.01% | +12.5% |
Q4 2019 | $5,041,000 | +44.2% | 42,887 | +5.4% | 0.01% | +33.3% |
Q3 2019 | $3,497,000 | +31.5% | 40,672 | -0.8% | 0.01% | +20.0% |
Q2 2019 | $2,659,000 | +11.6% | 41,018 | +7.6% | 0.01% | 0.0% |
Q1 2019 | $2,383,000 | +56.9% | 38,124 | -2.4% | 0.01% | +66.7% |
Q4 2018 | $1,519,000 | -0.4% | 39,058 | +46.0% | 0.00% | 0.0% |
Q3 2018 | $1,525,000 | -33.1% | 26,757 | -6.2% | 0.00% | -40.0% |
Q2 2018 | $2,278,000 | -5.0% | 28,525 | +3.1% | 0.01% | 0.0% |
Q1 2018 | $2,398,000 | +23.7% | 27,669 | -1.5% | 0.01% | +25.0% |
Q4 2017 | $1,939,000 | -35.8% | 28,084 | -15.5% | 0.00% | -42.9% |
Q3 2017 | $3,020,000 | +28.8% | 33,235 | +5.5% | 0.01% | +40.0% |
Q2 2017 | $2,344,000 | -11.7% | 31,491 | +11.1% | 0.01% | -16.7% |
Q1 2017 | $2,655,000 | +34.2% | 28,339 | +4.0% | 0.01% | +20.0% |
Q4 2016 | $1,979,000 | -26.2% | 27,239 | +6.1% | 0.01% | -28.6% |
Q3 2016 | $2,681,000 | +57.1% | 25,679 | +10.9% | 0.01% | +40.0% |
Q2 2016 | $1,707,000 | +79.5% | 23,149 | +36.9% | 0.01% | +66.7% |
Q1 2016 | $951,000 | -13.2% | 16,905 | +4.3% | 0.00% | -25.0% |
Q4 2015 | $1,095,000 | +66.2% | 16,215 | +14.2% | 0.00% | +100.0% |
Q3 2015 | $659,000 | -4.1% | 14,195 | +11.1% | 0.00% | 0.0% |
Q2 2015 | $687,000 | +150.7% | 12,775 | +123.3% | 0.00% | +100.0% |
Q1 2015 | $274,000 | – | 5,720 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |